# AP3S2

## Overview
The AP3S2 gene encodes the adaptor-related protein complex 3 subunit sigma 2, a critical component of the adaptor protein complex 3 (AP-3). This protein is involved in the intracellular trafficking of proteins, particularly in the sorting and transport of transmembrane proteins to lysosomes and related organelles. As a part of the clathrin-associated AP-3 complex, AP3S2 plays a vital role in clathrin-dependent endocytosis, facilitating the movement of proteins from endosomes to target membranes (Oh2019Molecular). The protein is predominantly active in the cytoplasm, especially within the trans-Golgi network and endosomal compartments, and is implicated in various physiological processes, including immune response and metabolic regulation (Guardia2018Neuronal). AP3S2 has been associated with several health conditions, such as type 2 diabetes and obesity, highlighting its clinical significance in metabolic disorders (Xiu2022Genetic; Ashour2020Evaluation).

## Function
The AP3S2 gene encodes a subunit of the clathrin-associated adaptor protein 3 (AP3) complex, which plays a critical role in protein trafficking within cells. This complex is involved in the transport of cargo proteins to target membranes using clathrin-coated vesicles, a process essential for clathrin-dependent endocytosis. This pathway is a major route for importing proteins into cells, including extracellular hormones, signal factors, receptor proteins, and synaptic membrane proteins (Oh2019Molecular).

In mammals, the AP3 complex, including AP3S2, is responsible for recruiting clathrin and facilitating the movement of proteins from endosomes to target membranes. This function is crucial in various tissues, such as adipocytes and pancreatic cells, and is implicated in conditions like liver fibrosis and cirrhosis associated with hepatitis C virus infection. AP3S2 is also linked to type 2 diabetes mellitus, although the precise mechanisms remain unclear (Oh2019Molecular).

AP3S2 may also play a role in viral entry into host cells by mimicking endogenous ligands to host cell receptors, thus participating in the innate immune response to viral infections through the TLR3 signaling pathway (Oh2019Molecular). The protein is active in the cytoplasm, particularly in the trans-Golgi network and endosomal compartments.

## Clinical Significance
The AP3S2 gene has been implicated in several health conditions, primarily through its association with type 2 diabetes (T2D) and peripheral artery disease (PAD). Studies have identified AP3S2 as a gene involved in protein transport, with variants linked to an increased risk of T2D in South Asians and Japanese populations (Xiu2022Genetic). Increased expression of AP3S2 has been associated with T2D across multiple tissue models, suggesting its significant role in the disease's pathogenesis (Torres2017Integrative). The gene is also part of a genetic region that includes other T2D-associated genes, indicating a complex regulatory network influencing diabetes risk (Torres2017Integrative).

In addition to its role in diabetes, AP3S2 has been studied in the context of obesity. A study on an Egyptian sample found correlations between SNPs in AP3S2 and obesity, highlighting its potential involvement in adiposity and related conditions (Ashour2020Evaluation). Furthermore, AP3S2 has been included in genetic risk panels for liver cirrhosis, although its specific role in this condition remains less clear (Chaiteerakij2011Telomerase). These findings underscore the gene's clinical significance in metabolic and possibly other disorders.

## Interactions
AP3S2 is a subunit of the adaptor protein complex 3 (AP-3), which plays a crucial role in vesicle-mediated transport processes. This complex is involved in the sorting of transmembrane proteins to various intracellular compartments, including lysosomes and related organelles. AP3S2 interacts with other subunits of the AP-3 complex, such as beta and delta subunits, to facilitate the formation of protein coats necessary for vesicle budding from the Golgi membrane (Guardia2018Neuronal). 

In the context of SARS-CoV-2 infection, AP3S2 is part of a receptor-mediated network where the viral envelope (E) protein binds to the AP3B1 cell-surface protein. This interaction triggers a cascade involving several proteins, including AP3S2, which participate in molecular pathways such as endosome transport and immune response (Ahmed2020Interplay). 

AP3S2 has also been implicated in type 2 diabetes (T2D) through its association with single nucleotide polymorphisms (SNPs) that affect its expression in multiple tissues. However, specific physical interactions of AP3S2 with other proteins or nucleic acids in the context of T2D remain unclear (Fadason2017Physical; Bouland2022Diabetes).


## References


[1. (Chaiteerakij2011Telomerase) Roongruedee Chaiteerakij and Lewis R. Roberts. Telomerase mutation: a genetic risk factor for cirrhosis. Hepatology, 53(5):1430–1432, April 2011. URL: http://dx.doi.org/10.1002/hep.24304, doi:10.1002/hep.24304. This article has 14 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/hep.24304)

[2. (Fadason2017Physical) Tayaza Fadason, Cameron Ekblad, John R. Ingram, William S. Schierding, and Justin M. O’Sullivan. Physical interactions and expression quantitative traits loci identify regulatory connections for obesity and type 2 diabetes associated snps. Frontiers in Genetics, October 2017. URL: http://dx.doi.org/10.3389/fgene.2017.00150, doi:10.3389/fgene.2017.00150. This article has 77 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2017.00150)

[3. (Bouland2022Diabetes) Gerard A. Bouland, Joline W. J. Beulens, Joey Nap, Arno R. van der Slik, Arnaud Zaldumbide, Leen M. ’t Hart, and Roderick C. Slieker. Diabetes risk loci-associated pathways are shared across metabolic tissues. BMC Genomics, May 2022. URL: http://dx.doi.org/10.1186/s12864-022-08587-5, doi:10.1186/s12864-022-08587-5. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12864-022-08587-5)

[4. (Xiu2022Genetic) Xuehao Xiu, Haoyang Zhang, Angli Xue, David N. Cooper, Li Yan, Yuedong Yang, Yuanhao Yang, and Huiying Zhao. Genetic evidence for a causal relationship between type 2 diabetes and peripheral artery disease in both europeans and east asians. BMC Medicine, August 2022. URL: http://dx.doi.org/10.1186/s12916-022-02476-0, doi:10.1186/s12916-022-02476-0. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12916-022-02476-0)

[5. (Ashour2020Evaluation) Esmat Ashour, Weaam Gouda, Lamiaa Mageed, Mie Afify, Waleed Hamimy, and Yehia M. Shaker. Evaluation of genetic susceptibility of six type ii diabetes genome-wide association tudies loci for obesity. Meta Gene, 26:100758, December 2020. URL: http://dx.doi.org/10.1016/j.mgene.2020.100758, doi:10.1016/j.mgene.2020.100758. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mgene.2020.100758)

[6. (Oh2019Molecular) Jae-Don Oh, Godfrey Bigirwa, Seokhyun Lee, and Ki-Duk Song. Molecular characterization and expression analysis of clathrin-associated adaptor protein 3-δ subunit 2 (ap3s2) in chicken. Korean Journal of Poultry Science, 46(1):31–37, March 2019. URL: http://dx.doi.org/10.5536/kjps.2019.46.1.31, doi:10.5536/kjps.2019.46.1.31. This article has 1 citations.](https://doi.org/10.5536/kjps.2019.46.1.31)

7. (Ahmed2020Interplay) Interplay of host regulatory network on SARS-CoV-2 binding and replication machinery. This article has 3 citations.

8. (Torres2017Integrative) Integrative cross tissue analysis of gene expression identifies novel type 2 diabetes genes. This article has 15 citations.

[9. (Guardia2018Neuronal) Carlos M Guardia, Raffaella De Pace, Rafael Mattera, and Juan S Bonifacino. Neuronal functions of adaptor complexes involved in protein sorting. Current Opinion in Neurobiology, 51:103–110, August 2018. URL: http://dx.doi.org/10.1016/j.conb.2018.02.021, doi:10.1016/j.conb.2018.02.021. This article has 56 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.conb.2018.02.021)